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Naturally occurring antioxidants, such as
vitamin E and selenium, have antimutagenic
and radioprotective properties that need further
examination with respect to long-term radiation
effects.  Modulation of endogenous antioxi-
dants, such as superoxide dismutase, may be
useful in specific radiotherapy protocols (1). It is
well established that ionizing radiation induces
the evolvement of free radicals and other reac-
tive species, (hydrated electrons and ions), in an
organism due to ionization of aqueous medium.
Among direct damaging effects to biomacro-
molecules, ionizing radiation induces free radi-
cal chain reactions, which lead to the appear-
ance of non-functional derivatised molecules
and thus disturbed physiological functions.
Unappropriate antioxidative defense (AD)
capacity for preventing formation and repair
capacity for elimination of the damaged mole-
cules results in pathological changes and fatal
outcome. After millions of years of exposure to
natural irradiation, living organisms have
adapted so that low levels of radiation cause
very little, if any harm. To examine molecular
basis of such an adaptation, one of the main
questions that should be answered is related to
the role of reactive species in the regulation of
biochemical i.e. physiological processes. A
direct regulatory role of reactive oxygen species
throughout their interaction with regulatory
molecules such as tyrosine kinases or nuclear
factor -kB was also reported (2).
Many tumor cells are in prooxidant status
resulting from increased production of oxygen
free radicals or decreased expression of antioxi-
dant enzymes (3). Antioxidant molecules, such
as glutathione and vitamin E and C as well as
antioxidant enzymes such as superoxide dismu-
tase, catalase and glutathione peroxidase, have
been long  believed to have protective and anti-
cancer activities by scavenging excess of free
radicals (4). New data  suggest that another
mechanism of action is possible. Redox  modu-
lation of gene expression is  well documented
(5,6). Antioxidants may play protective role also
through differential regulation of transcription-
al activator activities (7). Redox regulation of the
p53 tumor suppressor gene, which induces
blocks in the cell cycle and prevents gene ampli-
fication (8), is obvious because the removal of
reducing agents by dialysis completely inacti-
vated p53 DNA binding activity  (9).
In this volume, the Archive of Oncology has
published some papers related to these prob-
lems. Vitamin E supplementation produces an
improvement in the immune system and protec-
tion against disease other than cardiovascular
disease such as prostate cancer (10).  It will be
extremely difficult to do trials that adequately
probe the dose-effect curve for vitamin E for
each condition that it might affect, or to do stud-
ies of all the possible combinations of other
micronutritients that might act with vitamin E
to improve its effectiveness. Data from clinical
studies about level of vitamin E, in relation with
other lipid components and effect of vitamin E
supplementation may be very useful although
far from being ÒcompleteÒ. In vitro studies of the
effect of ionization radiation on antioxidant
enzymes in cell tissue cultures as well as protec-
tive effect of vitamin E gave more precise data
but the relation with in vivo situation must be
further verified. As Pryor said Ò Therefore, the
scientific community must recognize that there
never will be a time when the science is com-
pleteÓ (10), we may add that accumulation of
data about free radicals in cancer through scien-
tific papers, as in this volume of the Archive,
puts us closer to determination of antioxidantsÕ
role in vivo and possible antioxidant use in ther-
apy of cancer.
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